Global /China /Healthcare /Drug Manufacturers - Specialty & Generic /002412
chevron_leftBack
Hunan Hansen Pharmaceutical Co., Ltd. logo

Hunan Hansen Pharmaceutical Co., Ltd.

002412
SHE: 002412 Delayed
6.99CNY -0.3%
1.03 USD
As of 13 July 2026, Hunan Hansen Pharmaceutical Co., Ltd. has a market cap of $520.46M USD, ranking #14839 globally and #4632 in China. It ranks #1313 in the Healthcare sector, and #75 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
14839
1d: 0
1w: +4
1m: -
Country Rank
4632
1d: 0
1w: +2
1m: -
Sector Rank
1313
1d: 0
1w: +8
1m: -
Industry Rank
75
1d: 0
1w: 0
1m: -
Key Stats
Market Cap
$520.46MUSD
3.53B CNY
Enterprise Value
$443.74MUSD
3.01B CNY
Revenue (TTM)
$155.11MUSD
1.05B CNY
EBITDA (TTM)
$43.21MUSD
292.86M CNY
Net Income (TTM)
$25.38MUSD
172.02M CNY
EBITDA Margin
28%
Profit Margin
16%
PE Ratio
20.5
PS Ratio
3.4
PB Ratio
1.6
EV/EBITDA
10.3
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Zhengqing Liu open_in_new
Employees
1,675
Founded
1998
Website
hansenzy.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-0.3% 7.8% 7% 3.2% 11% 26%

News

Loading...

Markets

Exchange Ticker Price
Shenzhen Stock Exchange
MIC: XSHE
PRIMARY
002412
湖南汉森制药股份有限公司 Class A
ISIN: CNE100000PK2
Shares Out.:
503.2M1 Shares Float: 295.487M2
TV:
SA:
YF:
GF:
BA:
MS:
6.99 CNY
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Hunan Hansen Pharmaceutical Co., Ltd.

Hunan Hansen Pharmaceutical Co., Ltd. engages in the production and sale of traditional Chinese preparations in China and internationally. The company offers digestive system medicines; cardiovascular and cerebrovascular medicines; kidney-tonifying and urine-reducing medicines; trauma medicines; diagnostic medicines, etc. It provides medicines in injection, mixture, tablet, capsule, granule, syrup, decoction, tincture, and pill forms. Hunan Hansen Pharmaceutical Co., Ltd. is based in Yiyang, China.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (China)
Name
Market Cap diff.
PE
$15.84B
107.34B CNY
3K%
16.0
$9.09B
61.6B CNY
2K%
80.6
$5.21B
35.33B CNY
902%
20.0
$4.2B
28.47B CNY
707%
20.8
$3.26B
22.12B CNY
527%
8.1
$2.74B
18.55B CNY
426%
11.5
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
PE
$36.18B
108.92B ILS
7K%
24.2
$29.56B
6K%
-
CIPLA
$11.16B
1.06T INR
2K%
23.4
LUPIN
$11.05B
1.05T INR
2K%
22.7
$8.64B
7.57B EUR
2K%
-
AUROPHARMA
$8.47B
807.02B INR
2K%
23.1
chevron_leftBack